Completed NA INTERVENTIONAL 2-arm NCT00193778

Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation

A Randomized Trial To Assess The Impact Of Loco-Regional Treatment On Survival Of Patients With Metastatic Breast Cancer At First Presentation

Sponsor: Tata Memorial Hospital

Conditions Cancer of the Breast

Interventions No Loco-regional treatment Surgery for breast cancer

Updated 9 times since 2017 Last updated: Oct 7, 2020 Started: Feb 28, 2005 Primary completion: Jul 30, 2020 Completion: Jul 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00193778, this NA trial focuses on Cancer of the Breast and remains completed. Sponsored by Tata Memorial Hospital, it has been updated 9 times since 2005, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2020 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Apr 2020 — Nov 2020 [monthly]

Active Not Recruiting NA

▶ Show 4 earlier versions

May 2019 — Apr 2020 [monthly]

Active Not Recruiting NA
Jun 2018 — May 2019 [monthly]

Active Not Recruiting NA
Feb 2018 — Jun 2018 [monthly]

Active Not Recruiting NA

Phase: PHASE3 → NA
Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting PHASE3

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tata Memorial Hospital

Data source: Tata Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mumbai, India